Joseph Kwong, Ph.D. - Publications

Affiliations: 
2003 The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
Oncology, Pathology, Molecular Biology

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Chan LKY, Lau TS, Chung KY, Tam C, Cheung TH, Yim SF, Lee JHS, Leung RWT, Qin J, Or YYY, Lo KW, Kwong J. Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth. Cancers. 13. PMID 33652749 DOI: 10.3390/cancers13050980  0.441
2020 Man GCW, Wang J, Song Y, Wong JH, Zhao Y, Lau TS, Leung KT, Chan TH, Wang H, Kwong J, Ng TB, Wang CC. Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer. Bmc Cancer. 20: 964. PMID 33023525 DOI: 10.1186/s12885-020-07455-3  0.308
2020 Lau TS, Chan LK, Man GC, Wong CH, Lee JH, Yim SF, Cheung TH, McNeish IA, Kwong J. Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4/IKK2/SNARE-dependent exocytosis. Cancer Immunology Research. PMID 32354736 DOI: 10.1158/2326-6066.Cir-19-0616  0.456
2019 Lau T, Chan LK, Man GC, Kwong J. Abstract 1232: Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4-independent and dependent pathways Cancer Research. 79: 1232-1232. DOI: 10.1158/1538-7445.Am2019-1232  0.448
2018 Ling K, Jiang L, Liang S, Kwong J, Yang L, Li Y, PingYin, Deng Q, Liang Z. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system. Journal of Ovarian Research. 11: 36. PMID 29716628 DOI: 10.1186/S13048-018-0403-2  0.447
2018 Zhang T, Zhou J, Man GCW, Leung KT, Liang B, Xiao B, Ma X, Huang S, Huang H, Hegde VL, Zhong Y, Li Y, Kong GWS, Yiu AK, Kwong J, et al. MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. European Journal of Immunology. PMID 29460338 DOI: 10.1002/Eji.201747417  0.335
2018 Wang JZ, Xiong YJ, Man GCW, Chen XY, Kwong J, Wang CC. Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis. Archives of Gynecology and Obstetrics. PMID 29327157 DOI: 10.1007/S00404-018-4648-1  0.381
2017 Cui L, Liang B, Yang Y, Zhu M, Kwong J, Zheng H, Wang CC. Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells. Oncotarget. 8: 101634-101648. PMID 29254192 DOI: 10.18632/Oncotarget.21356  0.429
2017 Yang X, Wang CC, Lee WYW, Trovik J, Chung TKH, Kwong J. Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. Cancer Letters. PMID 29107108 DOI: 10.1016/J.Canlet.2017.10.028  0.383
2017 Wang J, Man GCW, Chan TH, Kwong J, Wang CC. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer. Cancer Letters. PMID 29024813 DOI: 10.1016/J.Canlet.2017.09.054  0.473
2017 Yeung TL, Leung CS, Wong KK, Gutierrez-Hartmann A, Kwong J, Gershenson DM, Mok SC. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Oncotarget. PMID 28199976 DOI: 10.18632/Oncotarget.15208  0.531
2017 Lau TS, Chan LK, Wong EC, Hui CW, Sneddon K, Cheung TH, Yim SF, Lee JH, Yeung CS, Chung TK, Kwong J. A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR. Oncogene. PMID 28166193 DOI: 10.1038/Onc.2016.509  0.496
2017 Lau T, Chan LK, Cheung T, Yim S, Lee JH, Kwong J. Abstract 648: Interferon-gamma induces PD-L1 expression via IFNGR-JAK-STAT pathway in ovarian cancer Cancer Research. 77: 648-648. DOI: 10.1158/1538-7445.Am2017-648  0.46
2017 Yang X, Zhao Y, Sun K, Li Y, Zhou J, Wang J, Sun H, Wang CC, Kwong J, Wang H, Chung TKH. Abstract 3448: LncRNA HAND2-AS1 inactivates neuromedin U (NMU) and inhibits tumor invasion and metastasis in endometrioid endometrial carcinoma Cancer Research. 77: 3448-3448. DOI: 10.1158/1538-7445.Am2017-3448  0.448
2017 Cui L, Bo L, Yang Y, Zhu M, Kwong J, Zheng H, Wang CC. Abstract 3172: Inhibition of coiled coil domain containing protein 69 (CCDC69) enhance platinum-mediated apoptosis in ovarian cancer cells Cancer Research. 77: 3172-3172. DOI: 10.1158/1538-7445.Am2017-3172  0.496
2017 Wang J, Man CW, Yang X, Kwong J, Dou QP, Chan TH, Wang CC. Abstract 162: A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate served as a potentially novel angiogenesis inhibitor in endometrioid endometrial cancer Cancer Research. 77: 162-162. DOI: 10.1158/1538-7445.Am2017-162  0.404
2016 Lau T, Chan LK, Wong C, Man C, Cheung T, Yim S, Lee JH, Chung TK, Kwong J. Abstract 1566: A cancer-stroma-cancer interacting loop promotes peritoneal metastasis of ovarian cancer through TNFα-TGFα-EGFR Cancer Research. 76: 1566-1566. DOI: 10.1158/1538-7445.Am2016-1566  0.483
2015 Cui L, Kwong J, Wang CC. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis. Journal of Ovarian Research. 8: 38. PMID 26077676 DOI: 10.1186/S13048-015-0168-9  0.45
2014 Lau TS, Chung TK, Cheung TH, Chan LK, Cheung LW, Yim SF, Siu NS, Lo KW, Yu MM, Kulbe H, Balkwill FR, Kwong J. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. The Journal of Pathology. 232: 43-56. PMID 24014111 DOI: 10.1002/Path.4258  0.517
2013 Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang P, Chan LK, Zhang T, Yu J, Kwong J, Cheung TH, Chung T, Mak K, Sun H, Wang H. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma. Oncogene. 32: 3432-42. PMID 22907428 DOI: 10.1038/Onc.2012.360  0.345
2013 Lau T, Chung TK, Cheung T, Yim S, Wong C, Kwong J. Abstract A66: Colonization of human ovarian cancer cells is promoted by cancer-fibroblast interaction via TGFα-EGFR signaling Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A66  0.51
2012 Archibald KM, Kulbe H, Kwong J, Chakravarty P, Temple J, Chaplin T, Flak MB, McNeish IA, Deen S, Brenton JD, Young BD, Balkwill F. Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium. Oncogene. 31: 4987-95. PMID 22266861 DOI: 10.1038/Onc.2011.653  0.429
2012 Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM, Galletta L, Salako MA, Smyth JF, Hagemann T, et al. A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Research. 72: 66-75. PMID 22065722 DOI: 10.1158/0008-5472.Can-11-2178  0.417
2012 Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, Barroilhet LM, Ng AS, Wong RR, Wang VW, Mok SC, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. International Journal of Cancer. Journal International Du Cancer. 130: 1036-45. PMID 21400511 DOI: 10.1002/Ijc.26060  0.307
2011 Young JL, Koon EC, Kwong J, Welch WR, Muto MG, Berkowitz RS, Mok SC. Differential hRad17 expression by histologic subtype of ovarian cancer. Journal of Ovarian Research. 4: 6. PMID 21450056 DOI: 10.1186/1757-2215-4-6  0.485
2010 Lun SW, Man C, Hui JW, Chow C, Choy K, Kwong J, Lin H, To K, Lo K. Abstract 356: Targeting NOTCH3 signaling pathway enhances chemosensitivity in EBV-positive NPC cells Cancer Research. 70: 356-356. DOI: 10.1158/1538-7445.Am10-356  0.459
2010 Yeung T, Wong K, Gutierrez-Hartmann A, Kwong J, Welch WR, Gershenson DM, Birrer MJ, Mok SC. Abstract 3298: Elf3 as negative regulation for epithelial-mesenchymal transition in ovarian cancer Cancer Research. 70: 3298-3298. DOI: 10.1158/1538-7445.Am10-3298  0.413
2009 Kwong J, Kulbe H, Wong D, Chakravarty P, Balkwill F. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells. Molecular Cancer Therapeutics. 8: 1893-905. PMID 19567818 DOI: 10.1158/1535-7163.Mct-08-0966  0.479
2009 Kwong J, Chan FL, Wong KK, Birrer MJ, Archibald KM, Balkwill FR, Berkowitz RS, Mok SC. Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia (New York, N.Y.). 11: 529-41. PMID 19484142 DOI: 10.1593/neo.09112  0.375
2009 Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, Trieu V, Desai N, Mok SC, Motamed K. Aberrant promoter methylation of SPARC in ovarian cancer. Neoplasia (New York, N.Y.). 11: 126-35. PMID 19177197 DOI: 10.1593/Neo.81146  0.443
2009 Nevadunsky NS, Barbieri JS, Kwong J, Merritt MA, Welch WR, Berkowitz RS, Mok SC. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecologic Oncology. 112: 325-30. PMID 18937968 DOI: 10.1016/J.Ygyno.2008.09.006  0.477
2008 Park DC, Yeo SG, Wilson MR, Yerbury JJ, Kwong J, Welch WR, Choi YK, Birrer MJ, Mok SC, Wong KK. Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer. Neoplasia (New York, N.Y.). 10: 964-72. PMID 18714397 DOI: 10.1593/neo.08604  0.416
2007 Litkouhi B, Kwong J, Lo CM, Smedley JG, McClane BA, Aponte M, Gao Z, Sarno JL, Hinners J, Welch WR, Berkowitz RS, Mok SC, Garner EI. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. Neoplasia (New York, N.Y.). 9: 304-14. PMID 17460774 DOI: 10.1593/Neo.07118  0.302
2007 Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes, Chromosomes & Cancer. 46: 171-80. PMID 17099870 DOI: 10.1002/Gcc.20398  0.498
2006 Kwong J, Lee JY, Wong KK, Zhou X, Wong DT, Lo KW, Welch WR, Berkowitz RS, Mok SC. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia (New York, N.Y.). 8: 268-78. PMID 16756719 DOI: 10.1593/Neo.05502  0.454
2005 Kwong J, Lo KW, Chow LS, To KF, Choy KW, Chan FL, Mok SC, Huang DP. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia (New York, N.Y.). 7: 67-74. PMID 15720818 DOI: 10.1593/Neo.04370  0.475
2005 Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. International Journal of Cancer. 113: 386-92. PMID 15455391 DOI: 10.1002/Ijc.20593  0.442
2004 Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. International Journal of Cancer. 109: 839-47. PMID 15027117 DOI: 10.1002/Ijc.20079  0.386
2004 Chow LS, Lo K, Kwong J, Wong AY, Huang DP. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma Oncology Reports. 12: 781-787. DOI: 10.3892/Or.12.4.781  0.364
2003 Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Molecular Carcinogenesis. 38: 170-8. PMID 14639656 DOI: 10.1002/Mc.10156  0.436
2002 Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. International Journal of Cancer. 98: 651-5. PMID 11920632 DOI: 10.1002/Ijc.10271  0.423
2000 Kwong J, Xuan JW, Chan PS, Ho SM, Chan FL. A Comparative Study of Hormonal Regulation of Three Secretory Proteins (Prostatic Secretory Protein-PSP94, Probasin, and Seminal Vesicle Secretion II) in Rat Lateral Prostate* *This work was supported by an RGC Earmarked Research Grant (CUHK 4131/00M) from the Hong Kong Research Grant Council (to F.L.C.) and a grant from the Medical Research Council of Canada (to J.W.X.). Endocrinology. 141: 4543-4551. PMID 28201023 DOI: 10.1210/Endo.141.12.7818  0.305
2000 Kwong J, Xuan JW, Choi HL, Chan PSF, Chan FL. PSP94 (or beta-microseminoprotein) is a secretory protein specifically expressed and synthesized in the lateral lobe of the rat prostate . The Prostate. 42: 219-229. PMID 10639193 DOI: 10.1002/(Sici)1097-0045(20000215)42:3<219::Aid-Pros8>3.0.Co;2-J  0.315
1999 Kwong J, Choi HL, Huang Y, Chan FL. Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell and Tissue Research. 298: 123-136. PMID 10555546 DOI: 10.1007/S004419900057  0.322
1999 Kwong J, Chan FL, Jiang S, Guo Y, Imasato Y, Sakai H, Koropatnick J, Chin JL, Xuan JW. Differential expression of PSP94 in rat prostate lobes as demonstrated by an antibody against recombinant GST‐PSP94 Journal of Cellular Biochemistry. 74: 406-417. PMID 10412042 DOI: 10.1002/(Sici)1097-4644(19990901)74:3<406::Aid-Jcb9>3.0.Co;2-0  0.322
1999 Xuan JW, Kwong J, Chan FL, Ricci M, Imasato Y, Sakai H, Fong GH, Panchal C, Chin JL. cDNA, genomic cloning, and gene expression analysis of mouse PSP94 (prostate secretory protein of 94 amino acids). Dna and Cell Biology. 18: 11-26. PMID 10025505 DOI: 10.1089/104454999315583  0.348
Show low-probability matches.